Anthony D'Adamio Bioventus Inc. (BVS) insider trading activity

BVS Quotes by TradingView

Anthony D'Adamio is SVP & General Counsel of Bioventus Inc.. Currently has a direct ownership of 118,178 shares of BVS, which is worth approximately $1.2 Million. The most recent transaction as insider was on Feb 18, 2025, when has been sold 4,380 shares (Class A Common Stock) at a price of $10.19 per share, resulting in proceeds of $44,632. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 118K
23.65% 3M change
159.11% 12M change
Total Value Held $1.2 Million

Anthony D'Adamio Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 18 2025
SELL
Open market or private sale
$44,632 $10.19 p/Share
4,380 Reduced 3.57%
118,178 Class A Common Stock
Feb 15 2025
BUY
Exercise of conversion of derivative security
-
12,980 Added 9.58%
122,558 Class A Common Stock
Dec 23 2024
SELL
Open market or private sale
$61,579 $10.53 p/Share
5,848 Reduced 5.07%
109,578 Class A Common Stock
Dec 20 2024
BUY
Exercise of conversion of derivative security
-
19,850 Added 14.67%
115,426 Class A Common Stock
Jun 21 2024
SELL
Open market or private sale
$32,885 $5.57 p/Share
5,904 Reduced 5.82%
95,576 Class A Common Stock
Jun 20 2024
BUY
Exercise of conversion of derivative security
-
19,850 Added 16.36%
101,480 Class A Common Stock
Jun 17 2024
SELL
Open market or private sale
$66,038 $5.84 p/Share
11,308 Reduced 12.17%
81,630 Class A Common Stock
Jun 15 2024
BUY
Exercise of conversion of derivative security
-
34,696 Added 27.18%
92,938 Class A Common Stock
Apr 11 2024
SELL
Open market or private sale
$14,506 $4.75 p/Share
3,054 Reduced 4.98%
58,242 Class A Common Stock
Apr 10 2024
BUY
Exercise of conversion of derivative security
-
9,925 Added 13.94%
61,296 Class A Common Stock
Mar 15 2024
SELL
Open market or private sale
$17,062 $5.46 p/Share
3,125 Reduced 5.73%
51,371 Class A Common Stock
Mar 14 2024
BUY
Exercise of conversion of derivative security
-
8,886 Added 14.02%
54,496 Class A Common Stock
Mar 15 2023
SELL
Open market or private sale
$4,738 $1.39 p/Share
3,409 Reduced 6.95%
45,610 Class A Common Stock
Mar 14 2023
BUY
Exercise of conversion of derivative security
-
8,887 Added 15.35%
49,019 Class A Common Stock
Apr 04 2022
SELL
Open market or private sale
$179,219 $11.19 p/Share
16,016 Reduced 28.52%
40,132 Class A Common Stock
Apr 01 2022
BUY
Exercise of conversion of derivative security
-
37,476 Added 40.03%
56,148 Class A Common Stock
Feb 14 2022
SELL
Open market or private sale
$15,515 $11.99 p/Share
1,294 Reduced 6.48%
18,672 Class A Common Stock
Feb 11 2022
BUY
Exercise of conversion of derivative security
-
4,400 Added 18.06%
19,966 Class A Common Stock
Feb 10 2022
BUY
Payment of exercise price or tax liability
$84,995 $12.88 p/Share
6,599 Added 29.77%
15,566 Class A Common Stock
Feb 10 2022
BUY
Exercise of conversion of derivative security
-
21,165 Added 48.85%
22,165 Class A Common Stock
Feb 11 2021
BUY
Open market or private purchase
$13,000 $13.0 p/Share
1,000 Added 50.0%
1,000 Common Stock
AD

Anthony D'Adamio

SVP & General Counsel
Durham, NC

Track Institutional and Insider Activities on BVS

Follow Bioventus Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BVS shares.

Notify only if

Insider Trading

Get notified when an Bioventus Inc. insider buys or sells BVS shares.

Notify only if

News

Receive news related to Bioventus Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BVS